ATE526058T1 - Saure feste orale zusammensetzungen ohne erosionspotential in speichel und verfahren zur bestimmung des erosionspotentials in speichel - Google Patents
Saure feste orale zusammensetzungen ohne erosionspotential in speichel und verfahren zur bestimmung des erosionspotentials in speichelInfo
- Publication number
- ATE526058T1 ATE526058T1 AT05762715T AT05762715T ATE526058T1 AT E526058 T1 ATE526058 T1 AT E526058T1 AT 05762715 T AT05762715 T AT 05762715T AT 05762715 T AT05762715 T AT 05762715T AT E526058 T1 ATE526058 T1 AT E526058T1
- Authority
- AT
- Austria
- Prior art keywords
- saliva
- erosion potential
- determining
- oral compositions
- potential
- Prior art date
Links
- 230000003628 erosive effect Effects 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 210000003296 saliva Anatomy 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 206010013781 dry mouth Diseases 0.000 abstract 1
- 235000019644 stimulating the production of saliva Nutrition 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/362—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/064—Chewing gum characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
- A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
- A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
- A23G9/325—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/18—Dental and oral disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200401148 | 2004-07-23 | ||
PCT/DK2005/000508 WO2006007856A2 (en) | 2004-07-23 | 2005-07-22 | Acidic solid oral compositions without erosive potential in saliva and method for determining erosive potential in saliva |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE526058T1 true ATE526058T1 (de) | 2011-10-15 |
Family
ID=35708527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05762715T ATE526058T1 (de) | 2004-07-23 | 2005-07-22 | Saure feste orale zusammensetzungen ohne erosionspotential in speichel und verfahren zur bestimmung des erosionspotentials in speichel |
Country Status (10)
Country | Link |
---|---|
US (3) | US20090169488A1 (de) |
EP (1) | EP1773453B1 (de) |
JP (1) | JP2008507480A (de) |
CN (1) | CN101060888B (de) |
AT (1) | ATE526058T1 (de) |
AU (1) | AU2005263337B2 (de) |
CA (1) | CA2574623C (de) |
DK (1) | DK1773453T3 (de) |
HK (1) | HK1114574A1 (de) |
WO (1) | WO2006007856A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008014227A1 (de) * | 2008-03-16 | 2009-10-01 | Nova Dentalia Zahnpflege Gmbh | Remineralisierende Speichelersatzmittel und Verfahren zu deren Herstellung |
DE102008014225A1 (de) * | 2008-03-16 | 2009-09-17 | MEDERER Süßwarenvertriebs GmbH | Remineralisierende Zahnpflegemittel und Verfahren zu deren Herstellung |
JP7037881B2 (ja) * | 2016-08-09 | 2022-03-17 | アサヒグループ食品株式会社 | 口腔内溶解性固形物 |
US20220241172A1 (en) * | 2019-07-08 | 2022-08-04 | Basf Se | Oral care gummies |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3734742A (en) | 1971-12-08 | 1973-05-22 | Merck & Co Inc | Stabilized beverages |
IE42129B1 (en) * | 1974-10-10 | 1980-06-04 | Procter & Gamble | Compositions for remineralizing tooth enamel |
US4080440A (en) | 1974-12-13 | 1978-03-21 | The Procter & Gamble Company | Method for remineralizing tooth enamel |
US4851221A (en) | 1985-02-19 | 1989-07-25 | Mission Pharmacal Company | Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid |
US4737375A (en) | 1985-12-26 | 1988-04-12 | The Procter & Gamble Company | Beverages and beverage concentrates nutritionally supplemented with calcium |
US4820506A (en) * | 1987-05-01 | 1989-04-11 | Research Foundation, State University Of New York | Salivary stimulant |
US5028446A (en) | 1987-07-31 | 1991-07-02 | Kraft General Foods, Inc. | Process for making calcium beverages containing rapidly solubilized calcium fumarate |
US5108761A (en) | 1990-10-01 | 1992-04-28 | The Procter & Gamble Company | Method of preventing tooth enamel erosion utilizing an acidic beverage containing calcium |
ATE198122T1 (de) * | 1992-10-21 | 2001-01-15 | Procter & Gamble | Konzentrierte, bioverfügbare kalziumquelle |
US5496558A (en) * | 1993-03-02 | 1996-03-05 | Block Drug Company Inc. | Solid form xerostomia product |
EP0634110A3 (en) | 1993-07-08 | 1995-02-01 | Eckes Ag | Fluid food. |
GB9603518D0 (en) | 1996-02-20 | 1996-04-17 | Smithkline Beecham Plc | Novel process |
AU4083597A (en) | 1996-09-27 | 1998-04-17 | Enamelon, Inc. | Improved products and methods for the remineralization and prevention of demineralization of teeth |
GB9717598D0 (en) * | 1997-08-19 | 1997-10-22 | Smithkline Beecham Plc | Novel composition and use |
US6120754A (en) * | 1998-03-11 | 2000-09-19 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Remineralization of teeth |
GB9819530D0 (en) * | 1998-09-09 | 1998-10-28 | Smithkline Beecham Plc | Novel compositions and use |
US6077557A (en) | 1998-11-20 | 2000-06-20 | General Mills, Inc. | Gel products fortified with calcium and method of preparation |
US6444252B1 (en) * | 1998-11-20 | 2002-09-03 | General Mills, Inc. | Methods of preparation of gel products fortified with calcium |
AU4476600A (en) * | 1999-04-22 | 2000-11-10 | Vanderbilt University | Polymeric encapsulation system promoting angiogenesis |
GB0007421D0 (en) | 2000-03-27 | 2000-05-17 | Smithkline Beecham Plc | Novel use |
-
2005
- 2005-07-22 JP JP2007521797A patent/JP2008507480A/ja active Pending
- 2005-07-22 AT AT05762715T patent/ATE526058T1/de not_active IP Right Cessation
- 2005-07-22 CN CN2005800245578A patent/CN101060888B/zh active Active
- 2005-07-22 AU AU2005263337A patent/AU2005263337B2/en active Active
- 2005-07-22 DK DK05762715.0T patent/DK1773453T3/da active
- 2005-07-22 EP EP05762715A patent/EP1773453B1/de active Active
- 2005-07-22 US US11/658,380 patent/US20090169488A1/en not_active Abandoned
- 2005-07-22 CA CA2574623A patent/CA2574623C/en active Active
- 2005-07-22 WO PCT/DK2005/000508 patent/WO2006007856A2/en active Application Filing
-
2008
- 2008-04-22 HK HK08104449.1A patent/HK1114574A1/xx unknown
-
2013
- 2013-10-24 US US14/062,745 patent/US9651541B2/en active Active
-
2017
- 2017-04-11 US US15/485,122 patent/US10660832B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2006007856A2 (en) | 2006-01-26 |
HK1114574A1 (en) | 2008-11-07 |
EP1773453A2 (de) | 2007-04-18 |
US9651541B2 (en) | 2017-05-16 |
JP2008507480A (ja) | 2008-03-13 |
US20140121274A1 (en) | 2014-05-01 |
DK1773453T3 (da) | 2012-01-16 |
US20170216167A1 (en) | 2017-08-03 |
US10660832B2 (en) | 2020-05-26 |
CA2574623C (en) | 2013-02-12 |
CN101060888A (zh) | 2007-10-24 |
EP1773453B1 (de) | 2011-09-28 |
CA2574623A1 (en) | 2006-01-26 |
US20090169488A1 (en) | 2009-07-02 |
WO2006007856A3 (en) | 2006-03-30 |
AU2005263337A1 (en) | 2006-01-26 |
CN101060888B (zh) | 2011-08-24 |
AU2005263337B2 (en) | 2009-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE459621T1 (de) | Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung | |
DE60335560D1 (de) | Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen | |
DE602004031462D1 (de) | Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung | |
ATE511753T1 (de) | Postnatale stammzellen und deren verwendungen | |
ATE350375T1 (de) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen | |
CY1113306T1 (el) | Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6 | |
LTC1608344I2 (lt) | Per burną vartojamos kladribino kompozicijos | |
DE602004006141D1 (de) | Monatinhaltige kaugummizusammensetzungen und verfahren zu ihrer herstellung | |
ATE385409T1 (de) | Komponenten und verfahren für die verbesserte herstellung von abdrücken | |
AT9566U3 (de) | Kopierfräseinrichtung zur herstellung von zahntechnischen werkstücken | |
HUP0204235A2 (hu) | Helyettesített glutárimidek és felhasználásuk IL-12 termelés inhibitorként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ATE269295T1 (de) | Btk inhibitoren und verfahren zur identifizierung und verwendung | |
ATE414519T1 (de) | Kombination aus einem nmda-antagonist und acetylcholinesterase-hemmern zur behandlung der alzheimer-krankheit | |
ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
NO20055741L (no) | Nye kjemiske forbindelser | |
ATE466009T1 (de) | Ccr5 antagonisten verwendbar für die behandlung von aids | |
DE60129518D1 (de) | Verwendung von einem Vasopressin-Antagonisten wie Conivaptan zur Herstellung eines Medikaments für die Behandlung der pulmonalen Hypertension | |
ATE522203T1 (de) | Pharmazeutische herstellung zur bindung von acetaldehyd in speichel, magen und dickdarm | |
ATE526058T1 (de) | Saure feste orale zusammensetzungen ohne erosionspotential in speichel und verfahren zur bestimmung des erosionspotentials in speichel | |
MXPA05007771A (es) | Procedimientos de tratamiento del dolor articular o para mejorar el sueno usando un agonista/antagonista de estrogeno. | |
ATE422201T1 (de) | 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen | |
TW200733954A (en) | Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same | |
DE60332862D1 (de) | 17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen | |
ATE450256T1 (de) | Verwendung von zusammensetzungen enthaltend kappa-opioidrezeptor-antagonisten zur behandlung von dissoziativen störungen | |
DE602004019528D1 (de) | Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |